Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website

DBV Technologies

DBV Technologies reported $0 in Debt for its fiscal quarter ending in June of 2022.

Debt Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 945K
BioCryst Pharmaceuticals BCRX:US USD 746.93M 13.65M
BioMarin Pharmaceutical BMRN:US USD 1.08B 1.48M
Esperion Therapeutics ESPR:US USD 260.32M 417K
Galectin Therapeutics GALT:US USD 49.94M 10.11M
Halozyme Therapeutics HALO:US USD 1.49B 11.72M
Incyte Corp INCY:US USD 32.85M 414K
Insmed INSM:US USD 1.16B 7.26M
Intercept Pharmaceuticals ICPT:US USD 333.04M 367K
Ionis Pharmaceuticals IONS:US USD 1.19B 2.36M
Neurocrine Biosciences NBIX:US USD 169.5M 100K
PTC Therapeutics PTCT:US USD 1.35B 3.4M
Sarepta Therapeutics SRPT:US USD 1.23B 310.01M
United Therapeutics UTHR:US USD 800M 0